N-Acetyl-Cysteine Increases Activity of Peanut-Shaped Gold Nanoparticles Against Biofilms Formed by Clinical Strains of Pseudomonas aeruginosa Isolated from Sputum of Cystic Fibrosis Patients

References

• Sawicki GS, Signorovitch JE, Zhang J, et al. Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution. Pediatr Pulmonol. 2012;47(1):44–52. doi:10.1002/ppul.21521
   PubMed Web of Science ®Google Scholar
• Montero MM, López Montesinos I, Knobel H, et al. Risk Factors for Mortality among Patients with. J Clin Med. 2020;9(2):847. doi:10.3390/jcm9020514
   Web of Science ®Google Scholar
• Okamoto K, Gotoh N, Nishino T. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob Agents Chemother. 2001;45(7):1964–1971. doi:10.1128/AAC.45.7.1964-1971.2001
   Web of Science ®Google Scholar
• Høiby N, Ciofu O, Bjarnsholt T. Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol. 2010;5(11):1663–1674. doi:10.2217/fmb.10.125
   PubMed Web of Science ®Google Scholar
• Bucki R, Niemirowicz K, Wnorowska U, et al. Polyelectrolyte-mediated increase of biofilm mass formation. BMC Microbiol. 2015;15:117. doi:10.1186/s12866-015-0457-x
   Web of Science ®Google Scholar
• Hurt K, Bilton D. Inhaled interventions in cystic fibrosis: mucoactive and antibiotic therapies. Respiration. 2014;88(6):441–448. doi:10.1159/000369533
   Web of Science ®Google Scholar
• Bucki R, Durnaś B, Wątek M, et al. Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics. Infect Drug Resist. 2018;11:77–86. doi:10.2147/IDR.S145337
   PubMed Web of Science ®Google Scholar
• Karygianni L, Ren Z, Koo H, Thurnheer T. Biofilm Matrixome: extracellular Components in Structured Microbial Communities. Trends Microbiol. 2020;28(8):668–681. doi:10.1016/j.tim.2020.03.016
   PubMed Web of Science ®Google Scholar
• Tseng BS, Zhang W, Harrison JJ, et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol. 2013;15(10):2865–2878. doi:10.1111/1462-2920.12155
   PubMed Web of Science ®Google Scholar
• Peterson BW, He Y, Ren Y, et al. Viscoelasticity of biofilms and their recalcitrance to mechanical and chemical challenges. FEMS Microbiol Rev. 2015;39(2):234–245. doi:10.1093/femsre/fuu008
   PubMed Web of Science ®Google Scholar
• Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10:140. doi:10.1186/1471-2180-10-140
   PubMed Web of Science ®Google Scholar
• Eroshenko D, Polyudova T, Korobov V. N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens. Microb Pathog. 2017;105:145–152. doi:10.1016/j.micpath.2017.02.030
   PubMed Web of Science ®Google Scholar
• Olofsson AC, Hermansson M, Elwing H. N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol. 2003;69(8):4814–4822. doi:10.1128/AEM.69.8.4814-4822.2003
   PubMed Web of Science ®Google Scholar
• Leite B, Gomes F, Teixeira P, Souza C, Pizzolitto E, Oliveira R. Combined effect of linezolid and N-acetylcysteine against Staphylococcus epidermidis biofilms. Enferm Infecc Microbiol Clin. 2013;31(10):655–659. doi:10.1016/j.eimc.2012.11.011
   Web of Science ®Google Scholar
• Suk JS, Boylan NJ, Trehan K, et al. N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles. Mol Ther. 2011;19(11):1981–1989. doi:10.1038/mt.2011.160
   PubMed Web of Science ®Google Scholar
• Suk JS, Lai SK, Boylan NJ, Dawson MR, Boyle MP, Hanes J. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine. 2011;6(2):365–375. doi:10.2217/nnm.10.123
   PubMed Web of Science ®Google Scholar
• Blasi F, Page C, Rossolini GM, et al. The effect of N-acetylcysteine on biofilms: implications for the treatment of respiratory tract infections. Respir Med. 2016;117:190–197. doi:10.1016/j.rmed.2016.06.015
   PubMed Web of Science ®Google Scholar
• Piktel E, Suprewicz T, Depciuch J, et al. Varied-shaped gold nanoparticles with nanogram killing efficiency as potential antimicrobial surface coatings for the medical devices. Sci Rep. 2021;11(1):12546. doi:10.1038/s41598-021-91847-3
   PubMed Web of Science ®Google Scholar
• Piktel E, Suprewicz L, Depciuch J, et al. Rod-shaped gold nanoparticles exert potent candidacidal activity and decrease the adhesion of fungal cells. Nanomedicine. 2020;15(28):2733–2752. doi:10.2217/nnm-2020-0324
   Web of Science ®Google Scholar
• Cabuzu D, Cirja A, Puiu R, Grumezescu AM. Biomedical applications of gold nanoparticles. Curr Top Med Chem. 2015;15(16):1605–1613. doi:10.2174/1568026615666150414144750
   PubMed Web of Science ®Google Scholar
• Chmielewska SJ, Skłodowski K, Depciuch J, et al. Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains. Pharmaceutics. 2021;13(3):425. doi:10.3390/pharmaceutics13030425
   Web of Science ®Google Scholar
• Trejo-Hernández A, Andrade-Domínguez A, Hernández M, Encarnación S. Interspecies competition triggers virulence and mutability in Candida albicans-Pseudomonas aeruginosa mixed biofilms. ISME J. 2014;8(10):1974–1988. doi:10.1038/ismej.2014.53
   PubMed Web of Science ®Google Scholar
• Garg N, Scholl C, Mohanty A, Jin R. The role of bromide ions in seeding growth of Au nanorods. Langmuir. 2010;26(12):10271–10276. doi:10.1021/la100446q
   Web of Science ®Google Scholar
• Grzelczak M, Pérez-Juste J, Mulvaney P, Liz-Marzán LM. Shape control in gold nanoparticle synthesis. Chem Soc Rev. 2008;37(9):1783–1791. doi:10.1039/b711490g
   PubMed Web of Science ®Google Scholar
• Jana NR, Gearheart L, Murphy CJ. Seed-Mediated Growth Approach for Shape-Controlled Synthesis of Spheroidal and Rod-like Gold Nanoparticles Using a Surfactant Template. Advances Materials. 2001;13(18):1389–1393. doi:10.1002/1521-4095(200109)13:18<1389::AID-ADMA1389>3.0.CO;2-F
   Web of Science ®Google Scholar
• Nikoobakht B, El-Sayed MA. Preparation and Growth Mechanism of Gold Nanorods (NRs) Using Seed-Mediated Growth Method. Chemistry of Materials. 2003;15(10):1957–1962. doi:10.1021/cm020732l
   Web of Science ®Google Scholar
• Depciuch J, Stec M, Kandler M, Baran J, Parlinska-Wojtan M. From spherical to bone-shaped gold nanoparticles-Time factor in the formation of Au NPs, their optical and photothermal properties. Photodiagnosis Photodyn Ther. 2020;30:101670. doi:10.1016/j.pdpdt.2020.101670
   PubMed Web of Science ®Google Scholar
• Wnorowska U, Piktel E, Durnaś B, Fiedoruk K, Savage PB, Bucki R. Use of ceragenins as a potential treatment for urinary tract infections. BMC Infect Dis. 2019;19(1):369. doi:10.1186/s12879-019-3994-3
   PubMed Web of Science ®Google Scholar
• Piktel E, Pogoda K, Roman M, et al. Sporicidal activity of ceragenin CSA-13 against Bacillus subtilis. Sci Rep. 2017;7:44452. doi:10.1038/srep44452
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Bos AC, Passé KM, Mouton JW, Janssens HM, Tiddens HA. The fate of inhaled antibiotics after deposition in cystic fibrosis: how to get drug to the bug? J Cyst Fibros. 2017;16(1):13–23. doi:10.1016/j.jcf.2016.10.001
   PubMed Web of Science ®Google Scholar
• Shigeta M, Tanaka G, Komatsuzawa H, Sugai M, Suginaka H, Usui T. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy. 1997;43(5):340–345. doi:10.1159/000239587
   PubMed Web of Science ®Google Scholar
• Walters MC, Roe F, Bugnicourt A, Franklin MJ, Stewart PS. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 2003;47(1):317–323. doi:10.1128/aac.47.1.317-323.2003
   PubMed Web of Science ®Google Scholar
• Pai VB, Nahata MC. Efficacy and safety of aerosolized tobramycin in cystic fibrosis. Pediatr Pulmonol. 2001;32(4):314–327. doi:10.1002/ppul.1125
   Web of Science ®Google Scholar
• Moreau-Marquis S, Stanton BA, O’Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm Pharmacol Ther. 2008;21(4):595–599. doi:10.1016/j.pupt.2007.12.001
   PubMed Web of Science ®Google Scholar
• Sherrard LJ, Tunney MM, Elborn JS. Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis. Lancet. 2014;384(9944):703–713. doi:10.1016/S0140-6736(14)61137-5
   PubMed Web of Science ®Google Scholar
• Nasser F, Davis A, Valsami-Jones E, Lynch I. Shape and Charge of Gold Nanomaterials Influence Survivorship, Oxidative Stress and Moulting of Daphnia magna. Nanomaterials. 2016;6(12):222. doi:10.3390/nano6120222
   Web of Science ®Google Scholar
• Bhatia E, Banerjee R. Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection. J Mater Chem B. 2020;8(22):4890–4898. doi:10.1039/d0tb00158a
   PubMed Web of Science ®Google Scholar
• Li X, Robinson SM, Gupta A, et al. Functional gold nanoparticles as potent antimicrobial agents against multi-drug-resistant bacteria. ACS Nano. 2014;8(10):10682–10686. doi:10.1021/nn5042625
   PubMed Web of Science ®Google Scholar
• Elbehiry A, Al-Dubaib M, Marzouk E, Moussa I. Antibacterial effects and resistance induction of silver and gold nanoparticles against Staphylococcus aureus-induced mastitis and the potential toxicity in rats. Microbiologyopen. 2019;8(4):e00698. doi:10.1002/mbo3.698
   PubMed Web of Science ®Google Scholar
• Lee B, Lee DG. Synergistic antibacterial activity of gold nanoparticles caused by apoptosis-like death. J Appl Microbiol. 2019;127(3):701–712. doi:10.1111/jam.14357
   PubMed Web of Science ®Google Scholar
• Ruddaraju LK, Pammi SVN, Guntuku GS, Padavala VS, Kolapalli VRM. A review on anti-bacterials to combat resistance: from ancient era of plants and metals to present and future perspectives of green nano technological combinations. Asian J Pharm Sci. 2020;15(1):42–59. doi:10.1016/j.ajps.2019.03.002
   PubMed Web of Science ®Google Scholar
• Niemirowicz K, Piktel E, Wilczewska AZ, et al. Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins. Int J Nanomedicine. 2016;11:5443–5455. doi:10.2147/IJN.S113706
   Web of Science ®Google Scholar
• Slomberg DL, Lu Y, Broadnax AD, Hunter RA, Carpenter AW, Schoenfisch MH. Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl Mater Interfaces. 2013;5(19):9322–9329. doi:10.1021/am402618w
   PubMed Web of Science ®Google Scholar
• Li X, Yeh YC, Giri K, et al. Control of nanoparticle penetration into biofilms through surface design. Chem Commun (Camb). 2015;51(2):282–285. doi:10.1039/c4cc07737g
   PubMed Web of Science ®Google Scholar
• Piktel E, Ościłowska I, Suprewicz Ł, et al. ROS-Mediated Apoptosis and Autophagy in Ovarian Cancer Cells Treated with Peanut-Shaped Gold Nanoparticles. Int J Nanomedicine. 2021;Volume 16:1993–2011. doi:10.2147/IJN.S277014
   Web of Science ®Google Scholar
• Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 2008;4(11):e1000213. doi:10.1371/journal.ppat.1000213
   PubMed Web of Science ®Google Scholar
• Hiebner DW, Barros C, Quinn L, Vitale S, Casey E. Surface functionalization-dependent localization and affinity of SiO. Biofilm. 2020;2:100029. doi:10.1016/j.bioflm.2020.100029
   Google Scholar
• Wnorowska U, Watek M, Durnas B, et al. Extracellular DNA as an essential component and therapeutic target of microbial biofilm. Medical Studies-Studia Medyczne. 2015;31(2):132–138. doi:10.5114/ms.2015.52912
   Google Scholar
• Carnerero JM, Jimenez-Ruiz A, Castillo PM, Prado-Gotor R. Covalent and Non-Covalent DNA-Gold-Nanoparticle Interactions: new Avenues of Research. Chemphyschem. 2017;18(1):17–33. doi:10.1002/cphc.201601077
   Web of Science ®Google Scholar
• Chiang WC, Nilsson M, Jensen P, et al. Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2013;57(5):2352–2361. doi:10.1128/AAC.00001-13
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Nistico L, Sambanthamoorthy K, et al. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol. 2008;8:173. doi:10.1186/1471-2180-8-173
   PubMed Web of Science ®Google Scholar
• Wallis C. Mucolytic therapy in cystic fibrosis. J R Soc Med. 2001;94(Suppl 40):17–24. doi:10.1177/014107680109440s06
   Google Scholar
• Bleem A, Christiansen G, Madsen DJ, et al. Protein Engineering Reveals Mechanisms of Functional Amyloid Formation in Pseudomonas aeruginosa Biofilms. J Mol Biol. 2018;430(20):3751–3763. doi:10.1016/j.jmb.2018.06.043
   Web of Science ®Google Scholar
• Liebeton K, Zacharias A, Jaeger KE. Disulfide bond in Pseudomonas aeruginosa lipase stabilizes the structure but is not required for interaction with its foldase. J Bacteriol. 2001;183(2):597–603. doi:10.1128/JB.183.2.597-603.2001
   PubMed Web of Science ®Google Scholar
• Braun P, Ockhuijsen C, Eppens E, Koster M, Bitter W, Tommassen J. Maturation of Pseudomonas aeruginosa elastase. Formation of the disulfide bonds. J Biol Chem. 2001;276(28):26030–26035. doi:10.1074/jbc.M007122200
   Web of Science ®Google Scholar
• Chen EY, Wang YC, Chen CS, Chin WC. Functionalized positive nanoparticles reduce mucin swelling and dispersion. PLoS One. 2010;5(11):e15434. doi:10.1371/journal.pone.0015434
   Web of Science ®Google Scholar
• Chen EY, Daley D, Wang YC, Garnica M, Chen CS, Chin WC. Functionalized carboxyl nanoparticles enhance mucus dispersion and hydration. Sci Rep. 2012;2:211. doi:10.1038/srep00211
   Web of Science ®Google Scholar
• Deng L, Luo M, Wang J, et al. Fe2O3 Nanoparticles Cause Alteration of Microstructure and Rheological Properties of Simulated Mucus. Am J Respir Crit Care Med. 2016;1:85.
   Google Scholar
• Cazzola M, Calzetta L, Page C, et al. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. Eur Respir Rev. 2015;24(137):451–461. doi:10.1183/16000617.00002215
   PubMed Web of Science ®Google Scholar
• Kapoor P, Murphy P. Combination antibiotics against. Heliyon. 2018;4(3):e00562. doi:10.1016/j.heliyon.2018.e00562
   Web of Science ®Google Scholar
• Campana S, Taccetti G, Farina S, Ravenni N, de Martino M. Antimicrobial susceptibility and synergistic activity of meropenem against Gram-negative non-fermentative bacteria isolated from cystic fibrosis patients. J Chemother. 2003;15(6):551–554. doi:10.1179/joc.2003.15.6.551
   PubMed Web of Science ®Google Scholar
• Habash MB, Goodyear MC, Park AJ, et al. Potentiation of Tobramycin by Silver Nanoparticles against Pseudomonas aeruginosa Biofilms. Antimicrob Agents Chemother. 2017;61(11). doi:10.1128/AAC.00415-17
   Web of Science ®Google Scholar
• Habash MB, Park AJ, Vis EC, Harris RJ, Khursigara CM. Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms. Antimicrob Agents Chemother. 2014;58(10):5818–5830. doi:10.1128/AAC.03170-14
   PubMed Web of Science ®Google Scholar
• Salman M, Rizwana R, Khan H, et al. Synergistic effect of silver nanoparticles and polymyxin B against biofilm produced by. Artif Cells Nanomed Biotechnol. 2019;47(1):2465–2472. doi:10.1080/21691401.2019.1626864
   PubMed Web of Science ®Google Scholar